Morningstar

DNA Nanobots Secures $3.5 Million Investment to Accelerate Non-Viral Gene Therapy Platform

DNA Nanobots, a pioneer in self-assembling nanoscale therapeutics, today announced it has secured $3.5 million in funding from a prominent, family office. This significant investment solidifies the ...
Business Wire

DNA Nanobots Gains Exclusive License to UC Berkeley Gene Editing Technology Platform for Non-Viral Gene Delivery Solution using DNA Nanoparticles and CRISPR-Cas

COLUMBUS, Ohio--(BUSINESS WIRE)--DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, today announced that it completed exclusive commercial licensing of a ...
Business Wire

DNA Nanobots Adds John C. Byrd, M.D. to Scientific Advisory Board to Help Guide Its Next Generation DNA Nanoparticle Targeted Drug Delivery Platform

COLUMBUS, Ohio--(BUSINESS WIRE)--DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, announced today that Dr. John C. Byrd, M.D., has joined its scientific ...
Hosted on MSN

Nanobots play 'follow the leader' by chasing chemical trails in microfluidic device

Researchers at Penn State demonstrate the first steps in the design of tiny particles that can perform specialized tasks, such as targeted delivery of drugs or other cargo. Subscribe to our newsletter ...